Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - OTHER FINANCING ACTIVITIES
Other Financing Activities ADAP - Adaptimmune Therapeutics plc
256 K
LAST VALUE
-41.92%
2 YEAR CAGR
-69.85%
5 YEAR CAGR
7.30%
10 YEAR CAGR